The diabetic foot: From art to science. The 18th Camillo Golgi lecture

Diabetologia

Volumn 47, Issue 8, 2004, Pages 1343-1353

  Boulton, Andrew J M ^a,b  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

Charcot neuroarthropathy; Diabetic foot; Diabetic neuropathy; Epidemiology; Wound healing

Indexed keywords

BIOLOGICAL MARKER; BISPHOSPHONIC ACID DERIVATIVE; PAMIDRONIC ACID; PLACEBO; SILICONE;

ACUTE DISEASE; ART; BONE TURNOVER; CHRONIC DISEASE; CHRONICITY; CLINICAL FEATURE; CLINICAL TRIAL; DIABETES MELLITUS; DIABETIC FOOT; DIABETIC NEUROPATHY; DISEASE ACTIVITY; ECONOMIC ASPECT; ETHNIC DIFFERENCE; ETHNOLOGY; FOOT AMPUTATION; FOOT DISEASE; HEALTH CARE COST; HISTOPATHOLOGY; HUMAN; INCIDENCE; INDIA; LIFESPAN; MEDICAL RESEARCH; MORPHOLOGY; NEUROPATHIC JOINT DISEASE; PERIPHERAL VASCULAR DISEASE; PHYSICAL STRESS; PRESSURE MEASUREMENT; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCIENCE; SKIN TEMPERATURE; SOCIAL ASPECT; UNITED KINGDOM; WEIGHT BEARING; WOUND HEALING;

DIABETIC ANGIOPATHIES; DIABETIC FOOT; DIABETIC NEUROPATHIES; FOOT ULCER; GREAT BRITAIN; HUMANS; INDIA; MODELS, BIOLOGICAL; PREVALENCE; SHOES;

EID: 4544221049     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-004-1463-y     Document Type: Review

References (105)

1. Pryce TD (1887) A case of perforating ulcers of both feet associated with diabetes and ataxic symptoms. Lancet 2:11-12
2. Boulton AJM (1990) Lawrence Lecture: the diabetic foot: neuropathic in aetiology? Diabetic Med 7:852-858
3. Brand PW (1983) The Diabetic Foot. In: Ellenberg M, Rifkin H (eds) Diabetes mellitus: theory and practice, 3rd edn. Med Exam Publishing, New York, pp 829-849
4. Bauman JH, Brand PW (1963) Measurement of pressure between foot and shoe. Lancet 1:629-632
5. Bergtholdt HT, Brand PW (1976) Temperature assessment and plantar inflammation. Lepr Rev 47:211-219
6. International Working Group on the Diabetic Foot (1999) International consensus on the diabetic foot. Amsterdam, The Netherlands
7. Shaw JE, Zimmett PZ (1999) The epidemiology of diabetic neuropathy. Diabetes Rev 6:245-252
8. Williams DRR, Airey M (2000) The size of the problem: epidemiological and economic aspects of the diabetic foot. In: Boulton AJM, Connor H, Cavanagh PR (eds) The foot in diabetes, 3rd edn. Wiley, Chichester, pp 3-17
9. Reiber GE, Ledoux WR (2002) Epidemiology of diabetic foot ulcers and amputations: evidence for prevention. In: Williams R, Herman W, Kinmonth AL, Wareham NJ (eds) The evidence base for diabetes care. Wiley, Chichester, pp 641-665
10. Carrington AL, Abbott CA, Griffiths J, Jackson N, Ross ERE van, Boulton AJM (2001) A foot care program for diabetic unilateral amputees. Diabetes Care 24:216-221
11. Kumar S, Ashe H, Fernando DJS, Tsigos C, Young RJ, Boulton AJM (1994) The prevalence of foot ulceration and its correlates in type 2 diabetic patients: a population-based study. Diabetic Med 11:480-484
12. Abbott CA, Carrington AL, Ashe H et al. (2002) The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabetic Med 20:377-384
13. Muller IS, Grauw WJ de, Gerwen WH van et al. (2002) Foot ulceration and lower limb amputation in type 2 diabetic patients in Dutch primary health care. Diabetes Care 25:570-574
14. Lavery LA, Armstrong DG, Wunderlich RP, Tredwell J, Boulton AJM (2003) Diabetic foot syndrome: evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes management cohort. Diabetes Care 26:1435-1438
15. Humphrey ARG, Thomas K, Dowse GK, Zimmet PZ (1996) Diabetes and non-traumatic lower extremity amputations. Incidence, risk factors and prevention: a 12 year follow-up study in Nauru. Diabetes Care 19:710-716
16. Behhadj MA (1998) La place du pied diabetique [in French]. Diabete Metab 24 [Suppl 1]:LXVII
17. Pendsey S (1994) Epidemiological aspects of the diabetic foot. J Diabetes Develop Countries 2:37-38
18. Young MJ, Veves A, Breddy JL, Boulton AJM (1994) The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds: a prospective study. Diabetes Care 17:557-560
19. Abbott CA, Vileikyte L, Williamson S, Carrington AL, Boulton AJM (1998) Multicentre study of the incidence of and predictive factors for diabetic neuropathic foot ulcers. Diabetes Care 21:1071-1075
20. Larsson J, Apelqvist J, Agardh GD, Stenstrom A (1995) Decreasing incidence of major amputation in diabetic patients: a consequence of a multidisciplinary foot care team approach? Diabetic Med 12:770-776
21. Trautner C, Haastert B, Spraul M, Giani C, Berger M (2001) Unchanged incidence of lower limb amputations in a German city 1990-1998. Diabetes Care 24:855-859
22. Trautner C, Haastert B, Giani C, Berger M (2002) Amputations and diabetes: a case-control study. Diabetic Med 19:35-40
23. No authors listed (1997) An audit of amputations in a rural health district. Practical Diabetes Int 14:175-178
24. Toledano H, Young MJ, Veves A, Boulton AJM (1993) Why do Asian diabetic patients have fewer foot ulcers than Caucasians? Diabetic Med 10 [Suppl 1]:539
25. Chaturvedi N, Abbott CA, Whalley A, Leggetter SY, Boulton AJM (2002) Risk of diabetes-related amputation in south Asians vs Europeans in the UK. Diabetic Med 19:99-106
26. Leggetter SY, Chaturvedi N, Fuller JH, Edmonds ME (2001) Ethnicity and risk of diabetes-related lower extremity amputation: a population-based, case-control study of Afro-Caribbeans and Europeans in the United Kingdom. Arch Int Med 162:73-78
27. Resnick HE, Valsania P, Phillips CL (1999) Diabetes mellitus and non-traumatic lower extremity amputation in black and white Americans: the national health and nutrition examination survey epidemiology follow-up study 1971-1992. Arch Int Med 159:2470-2475
28. American Diabetes Association (1999) Consensus development conference on diabetic wound care. Diabetes Care 22:1354-1360
29. Shearer A, Scuffham P, Gordois A, Ogleshy A (2003) Predicted costs and outcomes from reduced vibration detection in people with diabetes in the US. Diabetes Care 26:2305-2310
30. Ragnarson-Tennvall G, Apelqvist J (2001) Prevention of diabetes-related foot ulcers and amputations: a cost-utility analysis based on Markov model simulation. Diabetologia 44:2077-2087
31. Assal JP, Mehnert H, Tritschler HS, Sidorenko A, Keen H (2002) 'On your feet' workshop on the diabetic foot. J Diabet Comp 16:183-194
32. Ramsey SD, Newton K, Blough D et al. (1999) Incidence outcomes and costs of foot ulcers in patients with diabetes. Diabetes Care 22:382-387
33. Boulton AJM (2000) The pathway to ulceration: aetiopathogenesis. In: Boulton AJM, Connor H, Cavanagh PR (eds) The foot in diabetes, 3rd edn. Wiley, Chichester, pp 19-31
34. Reiber GE, Vileikyte L, Boyko EJ et al. (1999) Causal pathway for incident lower extremity ulcers in patients with diabetes from two settings. Diabetes Care 22:157-162
35. Boulton AJM, Hardisty CA, Betts RP et al. (1983) Dynamic foot pressure and other studies as diagnostic and management aids for diabetic neuropathy. Diabetes Care 6:26-33
36. Katoulis EC, Ebdon-Parry M, Hollis S et al. (1997) Postural instability in diabetic patients at risk of foot ulceration. Diabetic Med 14:296-300
37. Katoulis EC, Ebdon-Parry M, Lanshammar H et al. (1997) Gait abnormalities in diabetic neuropathy. Diabetes Care 20:1904-1907
38. Vileikyte L, Rubin RR, Leventhal H (2004) Psychological aspects of diabetic neuropathy and its late sequelae. Diab Metab Res Rev 20 [Suppl 1]:S13-S18
39. Young MJ, Boulton AJM, MaCleod AF, Williams DRR, Sonksen PH (1993) A multicentre study of the prevalence of diabetic peripheral neuropathy in the UK hospital clinic population. Diabetologia 36:150-154
40. Mayfield JA, Sugarman JR (2000) The use of the Semmes-Weinstein monofilament and other threshold tests for preventing foot ulceration and amputation in persons with diabetes. J Fam Pract 49 [Suppl 11]:S17-S29
41. Booth J, Young MJ (2000) Differences in the performance of commercially available monofilaments. Diabetes Care 23:984-988
42. Miranda-Palma B, Basu S, Mizel MS et al. (2003) The monofilament as the gold standard for foot ulcer risk screening: a reappraisal. Diabetes 53 [Suppl 1]:A63
43. Carrington AL, Shaw JE, Van Schie CHM, Abbott CA, Vileikyte L, Boulton AJM (2002) Can motor nerve conduction velocity predict foot problems in diabetes over a six year outcome period? Diabetes Care 25:2010-2015
44. Jude EB, Oyibo SO, Chalmers N, Boulton AJM (2001) Peripheral arterial disease in diabetic and non-diabetic patients: a comparison of severity and outcome. Diabetes Care 24:1433-1437
45. Lavery LA, Armstrong DG, Vela SA et al. (1998) Practical criteria for screening patients at high risk of diabetic foot ulceration. Arch Int Med 26:157-162
46. Murray HJ, Young MJ, Boulton AJM (1996) The relationship between callus formation, high pressures and neuropathy in diabetic foot ulceration. Diabetic Med 13:979-982
47. Valk GD, Kriegsman DM, Assendelf WJ (2002) Patient education for reducing diabetic foot ulceration: a systematic review. Endocrinol Metab Clin N Amer 31:633-658
48. McCabe CJ, Stevenson RC, Dolan AM (1998) Evaluation of a diabetic foot screening and prevention programme. Diabetic Med 15:80-84
49. Vileikyte L (2000) Psychological and behavioural issues in diabetic neuropathic foot ulceration. In: Boulton AJM, Connor H, Cavanagh PR (eds) The foot in diabetes, 3rd edn. Wiley, Chichester, pp 121-130
50. Veves A, Boulton AJM (1993) The optical pedobarograph. Clin Podiatr Med Surg 10:463-470
51. Boulton AJM, Betts RP, Franks CI et al. (1987) Abnormalities of foot pressure in early diabetic neuropathy. Diabetic Med 4:225-228
52. Boulton AJM, Betts RP, Franks CI, Ward JD, Duckworth T (1987) The natural history of foot pressure abnormalities in neuropathic diabetic subjects. Diabetes Res 5:73-77
53. Newrick PG, Cochrane T, Betts RP, Ward JD, Boulton AJM (1988) Reduced hyperaemic response under the neuropathic diabetic foot. Diabetic Med:570-573
54. Masson EA, Hay EM, Stockley I, Betts RP, Boulton AJM (1989) Abnormal foot pressures alone may not cause ulceration. Diabetic Med 6:426-429
55. Young MJ, Cavanagh PR, Thomas G et al. (1992) The effect of callus removal on dynamic plantar foot pressures in diabetic patients. Diabetic Med 9:55-57
56. Veves A, Young MJ, Murray HJ, Boulton AJM (1993) The risk of foot ulceration in diabetic patients with high foot pressures: a prospective study. Diabetologia 35:660-663
57. Lavery LA, Armstrong DG, Wunderlich RP, Tredwell J, Boulton AJM (2003) Predictive value of foot pressure assessment when part of a population-based diabetes disease management program. Diabetes Care 26:1069-1073
58. Cavanagh PR, Ulbrecht JS, Caputo GM (2000) What the practicing physician should know about diabetic foot biomechanics. In: Boulton AJM, Connor H, Cavanagh PR (eds) The foot in diabetes, 3rd edn. Wiley, Chichester, pp 33-60
59. Van Schie CHM, Abbott CA, Vileikyte L, Shaw JE, Hollis S, Boulton AJM (1999) A comparative study of Podotrack, a simple semiquantitative plantar pressure measuring device and the optical pedobarograph in the assessment of pressures under the diabetic foot. Diabetic Med 16:154-159
60. Bygrave CJ, Betts RP (1993) The Plantar tissue thickness in the foot: a new ultrasound technique for load-bearing measurements and a metatarsal head depth study. Foot 3:71-79
61. Abouaesha F, van Schie CHM, Griffiths GD, Young RJ, Boulton AJM (2001) Plantar tissue thickness is related to peak plantar pressure in the high risk diabetic foot. Diabetes Care 24:1270-1274
62. Abouaesha F, Schie CHM van, Armstrong DG, Boulton AJM (2004) Plantar soft tissue thickness predicts high peak plantar pressure in the diabetic foot. J Am Podiatr Med Assoc 94:39-42
63. Herring KM, Richie DH (1990) Friction blisters and sock fiber composition: a double-blind study. J Am Podiatr Med Assoc 80:63-71
64. Veves A, Masson EA, Fernando DJS, Boulton AJM (1989) Use of experimental padded hosiery to reduce abnormal foot pressures in diabetic neuropathy. Diabetes Care 12:653-655
65. Murray HJ, Veves A, Young MJ, Richie DH, Boulton AJM (1993) Role of experimental socks in the care of the high-risk diabetic foot. A multicentre evaluation study. Diabetes Care 16:1190-1192
66. Balkin S, Kaplan L (1991) Injectable silicone and the diabetic foot. A 25 year report. Foot 2:83-88
67. Van Schie CHM, Whalley A, Vileikyte L, Wignall T, Hollis S, Boulton AJM (2000) Efficacy of injected liquid silicone in the diabetic foot to reduce risk factors for ulceration: a randomized double-blind placebo-controlled trial. Diabetes Care 23:634-638
68. Van Schie CHM, Whalley A, Vileikyte L, Boulton AJM (2002) Efficacy of injected liquid silicone is related to peak plantar foot pressures in the neuropathic diabetic foot. Wounds 14:26-30
69. Van Schie CHM, Whalley A, Armstrong DG, Vileikyte L, Boulton AJM (2002) The effect of silicone injections in the diabetic foot on peak plantar pressure and plantar tissue thickness: a 2 year follow-up. Arch Phys Med Rehabil 83:919-923
70. Shaw JE, Boulton AJM (1995) The Charcot foot. Foot 5:65-70
71. Young MJ, Marshall A, Adams JE, Selby PL, Boulton AJM (1995) Osteopenia, neurological dysfunction and the development of Charcot neuroarthropathy. Diabetes Care 18:34-38
72. Selby PL, Young MJ, Boulton AJM (1994) Bisphosphonates: a new treatment for diabetic Charcot neuroarthropathy? Diabetic Med 11:28-31
73. Gough A, Abraha H, Purewal TS et al. (1997) Measurement of markers of osteoclastic and osteoblastic activity in patients with acute and chronic diabetic Charcot neuroarthropathy. Diabetic Med 14:517-531
74. Selby PL, Burgess J, Jude EB et al. (1998) Bone turnover markers in acute Charcot neuroarthropathy. Diabetologia 41 [Suppl 1]:A275
75. Jude EB, Selby PL, Burgess J et al. (2001) Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomized controlled trial. Diabetologia 44:2032-2037
76. McGill M, Molyneux L, Balton T et al. (2000) Response of Charcot's arthropathy to contact casting: skin temperature and radiographic correlates. Diabetologia 43:481-484
77. Thomas DW, Harding KG (2002) Wound healing. Br J Surg 89:1203-1205
78. Jeffcoate WJ, Harding KG (2003) Diabetic foot ulcers. Lancet 361:1545-1551
79. Jude EB, Blakytny R, Bulmer J, Boulton AJM, Ferguson MWJ (2002) Transforming growth factor-beta 1, 2, 3 and receptor type 1 and 2 in diabetic foot ulcers. Diabetic Med 19:440-447
80. Lobmann R, Ambrosch A, Schultz G et al. (2002) Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia 45:1011-1016
81. Boulton AJM, Armstrong DG (2003) Studies in plantar diabetic neuropathic ulcers; time for a paradigm shift? Diabetes Care 26:2689-2690
82. Boulton AJM, Bowker JH, Gadia M et al. (1986) Use of plaster casts the management of diabetic neuropathic foot ulcers. Diabetes Care 9:149-152
83. Mueller MJ, Diamond JE, Sinacore DR et al. (1989) Total contact casting in the treatment of diabetic plantar ulcers: controlled clinical trial. Diabetes Care 12:384-388
84. Mason J, O'Keeffe C, Hutchinson A, McIntosh A, Young R, Booth A (1999) A systematic review of foot ulcers in patients with type 2 diabetes mellitus II treatment. Diabetic Med 16:889-909
85. Armstrong DG, Nguyen HC, Lavery LA, Van Schie CHM, Boulton AJM, Harkless LB (2001) Offloading the diabetic foot wound: a randomized clinical trial. Diabetes Care 24:1019-1022
86. Lavery LA, Vela SA, Lavery DC, Quebedeaux TL (1996) Reducing dynamic foot pressures in high-risk diabetic subjects with foot ulcerations: a comparison of treatments. Diabetes Care 19:818-821
87. Baumhauer JF, Wervery R, McWilliams J, Harris GF, Shereff MJ (1997) A comparison study of plantar foot pressure in a standardized shoe, total contact cast prefabricated pneumatic walking brace. Foot Ankle Int 18:26-33
88. Armstrong DG, Lavery LA, Kimbriel HR, Nixon BP, Boulton AJM (2003) Activity patterns of patients with diabetic foot ulceration: patients with active ulceration may not adhere to a standard pressure offloading regimen. Diabetes Care 26:2595-2597
89. Veves A, Sheehan P, Pham HT (2002) A randomized controlled trial of Promogran vs standard treatment in the management of diabetic foot ulcers. Arch Surg 137:822-827
90. Armstrong DG, Short B, Espensen EH, Abu-Ramman PL, Nixon BP, Boulton AJM (2002) Technique for fabrication of an 'instant total contact cast' for treatment of neuropathic diabetic foot ulcers. J Am Pod Med Assoc 92:405-408
91. Katz I, Harlan A, Miranda-Palma B et al. (2004) A randomised trial of two irremovable offloading devices in the management of plantar neuropathic diabetic foot ulcers. Diabetes 54 [Suppl]:A85
92. Piaggesi A, Viacava P, Rizzo L et al. (2003) Semi-quantitative analysis of the histopathological features of the neuropathic foot ulcer - effects of pressure relief. Diabetes Care 26:3123-3128
93. Blakytny R, Jude EB, Gibson JM, Boulton AJM, Feguson MWJ (2000) Lack of insulin-like growth factor 1 (IGF-1) in the basal keratinocyte layer of diabetic skin and diabetic foot ulcers. J Pathol 190:589-594
94. Jude EB, Boulton AJM, Ferguson MWJ, Appleton I (1999) The role of nitric oxide synthase isoforms and arginase in the pathogenesis of diabetic foot ulcers: possible modulatory effectors of transforming growth factor beta 1. Diabetologia 42:748-757
95. Boulton AJM, Kirsner RS, Vileikyte L (2004) Neuropathic diabetic foot ulcers. N Engl J Med 351:48-55
96. Glaser R, Kiecolt-Glaser JK, Maruchas PT et al. (1999) Stress-related changes in proinflammatory cytokine production in wounds. Arch Gen Psychiatry 56:450-456
97. Kiecolt-Glaser J, Preacher JK, MacCallum RC et al. (2003) Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc Natl Acad Sci USA 100:9090-9095
98. Yang EV, Bone CM, MacCallum RC et al. (2002) Stress related modulation of matrix metalloproteinase expression. J Neuroimmunol 133:144-150
99. Badiavas EV, Falanga V (2001) Gene therapy. J Dermatol 138:1079-1081
100. Badiavas EV, Falanga V (2003) Treatment of chronic wounds with bone marrow-derived cells. Arch Dermatol 139:510-516
101. Naraynsingh V, Singh M, Ramdass MJ et al. (2002) Major lower limb amputation in Trinidad: a retrospective analysis. Diabetic Foot 5:81-83
102. Abbas ZG, Gill GV, Archibald LK (2002) The epidemiology of diabetic limb sepsis: an African perspective. Diabetic Med 19:895-899
103. Veves A, Uccioli L, Manes C et al. (1994) Comparison of risk factors for foot problems in diabetic patients attending teaching hospitals in four different European states. Diabetic Med 11:709-713
104. Morbach S, Lutale JK, Viswanathan V et al. (2004) Regional differences in risk factors and clinical presentation of diabetic foot lesions. Diabetic Med 21:91-95
105. Lipsky BA (2004) A report from the International Consensus on diagnosing and treating the infected diabetic foot. Diabet Met Res Rev 20 [Suppl 1]:S68-S77